Krsnaa Diagnostics Limited - Asset Resilience Ratio

Latest as of September 2025: 9.90%

Krsnaa Diagnostics Limited (KRSNAA) has an Asset Resilience Ratio of 9.90% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See KRSNAA current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs1.49 Billion
≈ $16.13 Million USD Cash + Short-term Investments

Total Assets

Rs15.07 Billion
≈ $162.94 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Krsnaa Diagnostics Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see KRSNAA current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Krsnaa Diagnostics Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Krsnaa Diagnostics Limited debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs1.49 Billion 9.9%
Total Liquid Assets Rs1.49 Billion 9.90%

Asset Resilience Insights

  • Limited Liquidity: Krsnaa Diagnostics Limited maintains only 9.90% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Krsnaa Diagnostics Limited Industry Peers by Asset Resilience Ratio

Compare Krsnaa Diagnostics Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Fleury S.A.
SA:FLRY3
Diagnostics & Research 13.87%
Australian Clinical Labs Ltd
AU:ACL
Diagnostics & Research 4.11%
Healius Ltd
AU:HLS
Diagnostics & Research 0.06%
Bionet
TWO:1784
Diagnostics & Research 41.08%
Scope Fluidics SA
WAR:SCP
Diagnostics & Research 16.51%
RHYTHM Biosciences Ltd
AU:RHY
Diagnostics & Research 2.74%
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%

Annual Asset Resilience Ratio for Krsnaa Diagnostics Limited (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Krsnaa Diagnostics Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 5.04% Rs645.90 Million
≈ $6.99 Million
Rs12.82 Billion
≈ $138.60 Million
-9.71pp
2024-03-31 14.75% Rs1.73 Billion
≈ $18.69 Million
Rs11.72 Billion
≈ $126.74 Million
+5.29pp
2023-03-31 9.46% Rs860.76 Million
≈ $9.31 Million
Rs9.10 Billion
≈ $98.40 Million
-8.05pp
2022-03-31 17.51% Rs1.53 Billion
≈ $16.59 Million
Rs8.76 Billion
≈ $94.75 Million
-3.70pp
2021-03-31 21.21% Rs1.28 Billion
≈ $13.87 Million
Rs6.05 Billion
≈ $65.38 Million
+2.34pp
2020-03-31 18.88% Rs1.19 Billion
≈ $12.86 Million
Rs6.30 Billion
≈ $68.13 Million
-0.60pp
2019-03-31 19.48% Rs1.03 Billion
≈ $11.14 Million
Rs5.29 Billion
≈ $57.21 Million
+17.89pp
2018-03-31 1.59% Rs46.67 Million
≈ $504.72K
Rs2.94 Billion
≈ $31.83 Million
--
pp = percentage points

About Krsnaa Diagnostics Limited

NSE:KRSNAA India Diagnostics & Research
Market Cap
$192.40 Million
Rs17.79 Billion INR
Market Cap Rank
#16770 Global
#874 in India
Share Price
Rs548.45
Change (1 day)
-0.51%
52-Week Range
Rs520.30 - Rs832.45
All Time High
Rs1020.15
About

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more